By Jonathan Rabinovitz
Stanford Medical School
Advocacy groups can play a vital role in advancing treatment of a disease, but a small but vocal group of parents of children with autism may be hindering as much as helping the latest efforts to promote research on the disorder.
Case in point: when the Interagency Autism Coordinating Committee meets on Oct. 23 to consider revisions to its strategic plan for autism research, it will no longer include one of its most esteemed scientists: Story Landis, PhD, director of the National Institute of Neurological Disorders and Stroke.
Landis had chosen to step down from the IACC in the face of complaints from some parents that she was dismissive of their concerns about vaccines being a cause of autism. Read more